| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $228.5M | +93.5% |
| SG&A Expense | $127.4M | +62.8% |
| Operating Income | -$355.9M | -81.2% |
| Pre-tax Income | -$169.1M | -69.1% |
| Income Tax | $0 | — |
| Net Income | -$169.1M | -69.1% |
| EPS (Basic) | -$0.36 | -16.1% |
| EPS (Diluted) | -$0.36 | -16.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $494.1M | -70.6% |
| Short-term Investments | $905.1M | — |
| Current Assets | $1.43B | -16.3% |
| Total Assets | $1.46B | -15.9% |
| Current Liabilities | $51.9M | +30.9% |
| Total Liabilities | $66.2M | -69.2% |
| Stockholders' Equity | $1.39B | -8.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$287.3M | -56.8% |
| Capital Expenditures | $1.1M | +152.9% |
| Investing Cash Flow | -$897.3M | — |
| Financing Cash Flow | $139K | -100.0% |
| Free Cash Flow | -$288.4M | -57.1% |